Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-08

Clinical Trial Update: StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating StrataMGT for reducing symptoms of Vulvar Lichen Sclerosus is currently recruiting. The study is sponsored by Andrew T. Gold…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • StrataMGT

Snippet

Sponsor: Andrew T. Goldstein, MD | Conditions: Vulvar Lichen Sclerosus | Phase 1 | Status: RECRUITING